neoplasm
• pancreatic tumors exhibit lower proliferation rates than in Krastm4Tyj Ptf1atm1.1(cre)Cvw Tg(MUC1)79.24Gend heterozygotes
(J:138959)
• mice exhibit carcinoma in situ in the pancreas
(J:234412)
|
• in 1 of 10 mice at 26 weeks
|
• mice exhibit high-grade PanIN lesions and carcinoma in situ, associated with disorganized glandular epithelium
(J:234412)
• mice treated with gemcitabine exhibit normal pancreatic glandular structure 26 weeks after the beginning of treatment
(J:234412)
|
• at 48 weeks, 6 of 10 mice develop metastasis to the lung and liver compared to 4 of 10 metastasis at 34 weeks of age in Krastm4Tyj Ptf1atm1.1(cre)Cvw Tg(MUC1)79.24Gend heterozygotes
|
endocrine/exocrine glands
• pancreatic tumors exhibit lower proliferation rates than in Krastm4Tyj Ptf1atm1.1(cre)Cvw Tg(MUC1)79.24Gend heterozygotes
(J:138959)
• mice exhibit carcinoma in situ in the pancreas
(J:234412)
|
• in 1 of 10 mice at 26 weeks
|
• mice exhibit high-grade PanIN lesions and carcinoma in situ, associated with disorganized glandular epithelium
(J:234412)
• mice treated with gemcitabine exhibit normal pancreatic glandular structure 26 weeks after the beginning of treatment
(J:234412)
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
adenoma | DOID:657 | J:138959 | ||
pancreatic carcinoma | DOID:4905 |
OMIM:260350 |
J:234412 |